Condition
Cell Therapy clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Cell Therapy clinical trials that are recruiting, at sites in 3 countries (most in United States (3), China (1), Indonesia (1)). By phase: Phase 1/2 (2), Phase 2 (1), Phase 1 (1), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest Cell Therapy clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Safety and better outcomes with FAP-targeted immunosuppressive dendritic cells in ischemic heart failure | Phase 1 | Hangzhou, Zhejiang / 浙江 | Recruiting | Apr 1, 2026 |
| MSC exosome treatment to repair blood vessel damage after preeclampsia | Phase 1/2 | Bandung, West Java | Recruiting | Sep 19, 2025 |
| CART19 treatment for lupus in young patients | Phase 1/2 | Philadelphia, Pennsylvania | Recruiting | Feb 21, 2025 |
| Using exercise to enhance immune cell therapy for blood cancer | Early Phase 1 | Tucson, Arizona | Recruiting | Oct 16, 2024 |
| Using Letermovir to prevent CMV reactivation in CAR T cell therapy patients | Phase 2 | Houston, Texas | Recruiting | Aug 28, 2024 |
All recruiting trials (5)
-
Safety and better outcomes with FAP-targeted immunosuppressive dendritic cells in ischemic heart failure
This trial tests whether a patient's own FAP-targeted immunosuppressive dendritic cells can be safely given alongside standard care to help people with ischemic cardiomyopathy.
-
MSC exosome treatment to repair blood vessel damage after preeclampsia
This study will see if IV infusions of mesenchymal stem cell–derived exosomes help repair damaged blood vessels in women who recently had preeclampsia.
-
CART19 treatment for lupus in young patients
This study is testing a new treatment called CART19 to see if it can help young people aged 12-29 with tough-to-treat lupus feel better and improve their health.
-
Using exercise to enhance immune cell therapy for blood cancer
This study tests if a short cycling exercise can improve immune cells from healthy donors to help treat blood cancers like leukemia and lymphoma more effectively.
-
Using Letermovir to prevent CMV reactivation in CAR T cell therapy patients
This study is testing if the drug Letermovir can help prevent CMV reactivation in patients who have received CAR T cell therapy and are already positive for the virus.
Related topics
Quick answers
How many Cell Therapy clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (3 trials), China (1 trial), Indonesia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Phase 2: 1, Phase 1: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.